MALDI-TOF Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome. At ASMS 2017, Vendors Focus on Software, Applications Premium With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms. MALDI-Based Fatty Acid Profiling Offers Infectious Disease Dx Potential Premium Scientists from the Colorado School of Mines have proposed a method to complement mass spec-based protein profiling. Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation Premium While much attention has focused on triple quads, MALDI-TOFs offer advantages in simplicity and throughput that could help them make clinical inroads. Map Diagnostics Developing Mass Spec Test for Down Syndrome Premium The UK firm is using MALDI-TOF mass spec technology to develop the test as a screening tool for the disorder as early as eight weeks into a pregnancy. Apr 29, 2015 Swedish Researchers Use MALDI-TOF to Type Clostridium Difficile Jul 19, 2013 MALDI Mass Spec Poised for Further Expansion into Clinical Microbiology Market Pending FDA Approvals Premium Jan 28, 2013 Ezose Sciences, Kyowa Hakko Ink Glycomics Pact Jan 3, 2013 Bruker Licenses IP from Erasmus Medical Center Mar 2, 2012 Biodesix Inks Deal to Test Veristrat in Phase III Clinical Trial for Kadmon Lung Cancer Drug Premium Jan 20, 2012 New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform Premium Dec 9, 2011 Glycomics Firm Ezose Inks Deal with Merck for Diabetes Biomarker Work Premium Dec 1, 2011 Bruker, Chungnam National University Partner on Glycan Analysis Aug 26, 2011 Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec Premium Aug 19, 2011 Proteomics Technologies Making Their Way into Pathogen Detection Premium May 6, 2011 Michigan Researchers ID Potential Glycoprotein Biomarker for Pancreatic Cancer Premium Apr 8, 2011 Top-Down Proteomics Inching Its Way Toward the Mainstream Premium Jan 21, 2011 Q&A: Oncologist Cristobal Belda-Iniesta on Proteomics' Role in Improving Cancer Treatments Premium Nov 5, 2010 Q&A: Metropolitan Museum of Art's Julie Arslanoglu on Proteomics in Art History and Conservation Premium Dec 3, 2009 Germany's Synlab to Use Bruker Mass Spec Tech for Microbial Identification Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.